These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 19880352)
1. NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients. Johansson SE; Hejdeman B; Hinkula J; Johansson MH; Romagné F; Wahren B; Wagtmann NR; Kärre K; Berg L Clin Immunol; 2010 Feb; 134(2):158-68. PubMed ID: 19880352 [TBL] [Abstract][Full Text] [Related]
2. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094 [TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408 [TBL] [Abstract][Full Text] [Related]
4. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses. Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813 [TBL] [Abstract][Full Text] [Related]
5. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Morvan M; David G; Sébille V; Perrin A; Gagne K; Willem C; Kerdudou N; Denis L; Clémenceau B; Folléa G; Bignon JD; Retière C Eur J Immunol; 2008 Dec; 38(12):3474-86. PubMed ID: 19016529 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors. Kamya P; Tallon B; Melendez-Pena C; Parsons MS; Migueles SA; Connors M; Miconiatis S; Song R; Boulet S; Bruneau J; Tremblay CL; Bernard NF; Clin Immunol; 2012 Jun; 143(3):246-55. PubMed ID: 22445844 [TBL] [Abstract][Full Text] [Related]
7. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Foley B; De Santis D; Lathbury L; Christiansen F; Witt C Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713 [TBL] [Abstract][Full Text] [Related]
8. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407 [TBL] [Abstract][Full Text] [Related]
9. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348 [TBL] [Abstract][Full Text] [Related]
10. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689 [TBL] [Abstract][Full Text] [Related]
11. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals. Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121 [TBL] [Abstract][Full Text] [Related]
12. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C. Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975 [TBL] [Abstract][Full Text] [Related]
18. Role of a KIR/HLA-C allorecognition system in pregnancy. Varla-Leftherioti M J Reprod Immunol; 2004 Jun; 62(1-2):19-27. PubMed ID: 15288178 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286 [TBL] [Abstract][Full Text] [Related]
20. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. Iannello A; Debbeche O; Samarani S; Ahmad A J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]